SARS-CoV-2 Nucleic Acid Test Kit (PCR-Fluorescent Probe Method)

Product Information

Product abbreviation: iFIND ECOV

Detection Target: SARS-CoV-2 (ORF1ab, E, N gene)

Cat. No. : 10T/box - 10210121A; 50T/box – 10210121B

The kit adopts a rapid detection system, which can simultaneously detect the ORF1ab, N and E gene targets of the (SARS-CoV-2), and is suitable for nucleic acid detection of throat swabs, nasal swabs and other samples.

SARS-CoV-2 Nucleic Acid Test Kit (PCR-Fluorescent Probe Method)

Current Status

Since the first report of the global COVID-19 pandemic at the end of 2019, the cumulative number of confirmed cases has exceeded 600 million (WHO, 2023). As an emerging and acute infectious disease, the COVID-19 virus continues to mutate. The emergence of the Omicron variant in 2022 led to recurring outbreaks in many countries, posing ongoing challenges to the global public health system. Traditional antigen detection methods have low sensitivity (< 80%), and are prone to false negative results in the early stage of infection with low viral load, leading to an increased risk of missed diagnosis.

iFIND Solution

The iFIND® SARS-CoV-2 Nucleic Acid Test Kit is a fully integrated, cartridge-based real-time PCR assay designed for the rapid and reliable qualitative detection of SARS-CoV-2 RNA, targeting ORF1ab, E, and N genes to ensure high sensitivity and robustness against viral mutations. Combining automated sample processing, nucleic acid amplification, and fluorescence detection within a closed system, the iFIND platform delivers accurate results with minimal hands-on time and reduced contamination risk. This streamlined workflow enables testing to be performed closer to the patient, supporting timely clinical decision-making across settings including hospitals, emergency departments, and near point-of-care environments, etc.